Venous Thrombosis (VT)

NASA Johnson Space Center is seeking commercial services to develop approaches for surveilling, reducing risk of, and preventing or treating venous thrombosis (VT) during spaceflight and exploration missions. The effort includes delivering a performance work statement (PWS) that outlines rationale, methodology, and countermeasure strategies. Offerors must be capable of providing technical solutions, past performance evidence, and competitive pricing. The contract will be awarded to the most advantageous offer based on technical acceptability, past performance, and price. Delivery is required FOB destination within 30 days of order receipt, and the period of performance runs from 01/07/2027 to 09/30/2031. • Scope: Research, development, and potential implementation of VT surveillance and treatment countermeasures for astronauts. • Deliverables: Technical approach, methodology documentation, and possibly prototype or validation data as defined in the PWS. • Timeline: Offers due 11/20/2026; performance period ~4 years 9 months. • Evaluation criteria: Technical acceptability (primary), past performance, then price. • Size standard: NAICS 541715, 1,000‑employee threshold; offerors must state size status.